News | Cardiac Diagnostics | February 15, 2019

IBM and Broad Institute Launch AI Initiative for Cardiovascular Disease Risk Prediction

New partnership will expand power of polygenic risk scores to help clinicians predict and prevent disease

IBM and Broad Institute Launch AI Initiative for Cardiovascular Disease Risk Prediction

February 15, 2019 — IBM Watson Health and the Broad Institute of MIT and Harvard are launching a research partnership aimed at developing powerful predictive models that will enable clinicians to identify patients at serious risk for cardiovascular disease. This three-year project will incorporate population- and hospital-based biobank data, genomic information, and electronic health records to build upon and expand the predictive power of polygenic scoring. The project will also plan to make insights and tools widely available to the research community, including methods to calculate an individual’s risk of developing common diseases based on millions of variants in the genome.

“I’m excited to build upon the advances we’ve made in polygenic risk scoring utilizing vast amount of genomic data,” said Sekar Kathiresan, director of the Center for Genomic Medicine at Massachusetts General Hospital (MGH) and institute member and director of the Cardiovascular Disease Initiative at the Broad Institute. “By coupling clinical data with genomic data, there is an exceptional opportunity to make polygenic risk scoring more robust and powerful, and ultimately transformative for patient care. Such transformation could never happen without these kinds of partnerships.”

Kathiresan will direct this new initiative along with Anthony Philippakis, chief data officer of the Broad Institute who trained as a cardiologist at Brigham and Women’s Hospital.

In recent years, scientists at the Broad Institute, MGH and Harvard Medical School have advanced a new kind of genome analysis called polygenic risk scores. The scores can identify subsets of the population who have a significantly higher risk of developing serious common diseases, including coronary artery disease, atrial fibrillation or breast cancer.

These tests, which use information from more than 6 million sites of variation in the human genome to ascertain risk for disease, can flag greater likelihood of developing serious conditions well before symptoms appear. Research suggests that up to 25 million people in the U.S. may be at more than triple the normal risk for coronary artery disease, and millions more may be at similar elevated risk for the other conditions, based on genetic variation alone. Such genomic information could allow physicians to find these individuals and intervene to prevent disease.

But more work needs to be done before this research is incorporated into clinical care, and that is the role of this new three-year partnership.

IBM and Broad Institute will expand the power of polygenic scoring by building artificial intelligence (AI)-based models for cardiac disease risk based on genomic information combined with patients' medical records and biomarkers. This project will also incorporate direct feedback from doctors and caregivers, all with the ultimate goal of assimilating such power into the medical system.

“With this new partnership, we have the opportunity to develop new approaches for the understanding and prediction of disease,” said Eric S. Lander, president and founding director of the Broad Institute. “I’m hopeful this will help advance precision medicine for patients.”

For more information: www.ibm.com/watson/health, www.broadinstitute.org

Related Content

FDA Clears Aidoc's AI Solution for Flagging Pulmonary Embolism
Technology | Artificial Intelligence | May 15, 2019
Artificial intelligence (AI) solutions provider Aidoc has been granted U.S. Food and Drug Administration (FDA)...
Basic artificial intelligence is already incorporated into several premium echocardiography systems. This example is from the Philips Epiq, which can take 3-D datasets and the AI automatically identifies and segments the cardiac anatomy. It then extracts the best images for each of the standard views for an echocardiogram to eliminate variation between operators. The next generation echo AI software will pull in data from the electronic medical records and imaging data to offer suggested diagnoses.

Basic artificial intelligence is already incorporated into several premium echocardiography systems. This example is from the Philips Epiq, where the AI takes 3-D datasets and automatically identifies and segments the cardiac anatomy. It then extracts the best images for each of the standard echocardiogram views to eliminate variation between operators. The next generation echo AI software will pull in data from the electronic medical records and imaging data to offer suggested diagnoses.

Feature | Artificial Intelligence | May 07, 2019 | Ross Upton
Artificial Intelligence has a multitude of impacts on our daily lives, from recommending movies based upon your Netfl
FDA Proposes New Review Framework for AI-based Medical Devices
News | Artificial Intelligence | April 02, 2019 | Jeff Zagoudis, Associate Editor
U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb, M.D., announced Tuesday the agency is pursuing a...
New Consensus Document Explores Ethical Use of AI in Radiology
News | Artificial Intelligence | March 05, 2019 | Jeff Zagoudis, Associate Editor
The American College of Radiology (ACR) is one of seven professional societies behind a new consensus document on the...
RSNA Offers First U.S. Spotlight Course on Artificial Intelligence
News | Artificial Intelligence | March 05, 2019
The Radiological Society of North America (RSNA) announced an expansion of its artificial intelligence (AI) education...
ACC Future Hub

Presenter delivers pitch at last year’s ACC Future Hub. This year during ACC.19, entrepreneurs will pitch software and hardware specific to cardiology in two categories– artificial intelligence and digitally enabled medical devices. (Image courtesy of ACC)

Feature | Artificial Intelligence | March 01, 2019 | By Greg Freiherr
Entrepreneurs to pitch innovative ideas at ACC
Siemens Healthineers Demonstrates Artificial Intelligence, Healthcare Digitalization at HIMSS19
News | Artificial Intelligence | February 13, 2019
At the 2019 Healthcare Information and Management Systems Society (HIMSS) global conference and exhibition, Feb. 11-15...
Overlay Init